These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37572800)
1. The genetic polymorphisms and activity of glyoxalase 1 as a risk factor for acute coronary syndrome in South Indians with type 2 diabetes mellitus. Bora S; Adole PS; Vinod KV; Pillai AA; Ahmed S Gene; 2023 Nov; 885():147701. PubMed ID: 37572800 [TBL] [Abstract][Full Text] [Related]
2. Association between Zeng Q; Yang T; Wei W; Zou D; Wei Y; Han F; He J; Huang J; Guo R Front Endocrinol (Lausanne); 2023; 14():1235581. PubMed ID: 38027126 [TBL] [Abstract][Full Text] [Related]
5. Association between carbonyl stress markers and the risk of acute coronary syndrome in patients with type 2 diabetes mellitus-A pilot study. Bora S; Adole PS; Motupalli N; Pandit VR; Vinod KV Diabetes Metab Syndr; 2020; 14(6):1751-1755. PubMed ID: 32932181 [TBL] [Abstract][Full Text] [Related]
6. GLO1 gene polymorphisms and their association with retinitis pigmentosa: a case-control study in a Sicilian population. Donato L; Scimone C; Nicocia G; Denaro L; Robledo R; Sidoti A; D'Angelo R Mol Biol Rep; 2018 Oct; 45(5):1349-1355. PubMed ID: 30099685 [TBL] [Abstract][Full Text] [Related]
7. Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project. Degaffe GH; Vander Jagt DL; Bobelu A; Bobelu J; Neha D; Waikaniwa M; Zager P; Shah VO J Diabetes Complications; 2008; 22(4):267-72. PubMed ID: 18413187 [TBL] [Abstract][Full Text] [Related]
8. Role of glyoxalase I gene polymorphisms in late-onset epilepsy and drug-resistant epilepsy. Tao H; Si L; Zhou X; Liu Z; Ma Z; Zhou H; Zhong W; Cui L; Zhang S; Li Y; Ma G; Zhao J; Huang W; Yao L; Xu Z; Zhao B; Li K J Neurol Sci; 2016 Apr; 363():200-6. PubMed ID: 27000251 [TBL] [Abstract][Full Text] [Related]
9. The Relationship Between GAPDH Gene Polymorphism and Risk of Acute Coronary Syndrome in South Indians with Type 2 Diabetes Mellitus. Bora S; Adole PS; Vinod KV; Pillai AA; Ahmed S Biochem Genet; 2024 Jul; ():. PubMed ID: 38969817 [TBL] [Abstract][Full Text] [Related]
10. Glyoxalase I and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes. Wu JC; Li XH; Wang JB; Tang JF; Wang YF; Peng YD Genet Test Mol Biomarkers; 2011 Apr; 15(4):273-9. PubMed ID: 21294693 [TBL] [Abstract][Full Text] [Related]
11. Clinical Implications of Glyoxalase1 Gene Polymorphism and Elevated Levels of the Reactive Metabolite Methylglyoxal in the Susceptibility of Type 2 Diabetes Mellitus in the Patients from Asir and Tabuk Regions of Saudi Arabia. Alhujaily M; Mir MM; Mir R; Alghamdi MAA; Wani JI; Sabah ZU; Elfaki I; Alnour TMS; Jeelani M; Abomughaid MM; Alharbi SA J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455754 [TBL] [Abstract][Full Text] [Related]
12. Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes. Škrha J; Muravská A; Flekač M; Horová E; Novák J; Novotný A; Prázný M; Škrha J; Kvasnička J; Landová L; Jáchymová M; Zima T; Kalousová M Physiol Res; 2014; 63(Suppl 2):S283-91. PubMed ID: 24908234 [TBL] [Abstract][Full Text] [Related]
13. Association of Abirami S; Adole PS; Vinod KV Genet Test Mol Biomarkers; 2024 Mar; 28(3):114-122. PubMed ID: 38471098 [No Abstract] [Full Text] [Related]
14. Common variants in glyoxalase I do not increase chronic pancreatitis risk. Kaune T; Hollenbach M; Keil B; Chen JM; Masson E; Becker C; Damm M; Ruffert C; Grützmann R; Hoffmeister A; Te Morsche RHM; Cavestro GM; Zuppardo RA; Saftoiu A; Malecka-Panas E; Głuszek S; Bugert P; Lerch MM; Weiss FU; Zou WB; Liao Z; Hegyi P; Drenth JP; Riedel J; Férec C; Scholz M; Kirsten H; Tóth A; Ewers M; Witt H; Griesmann H; Michl P; Rosendahl J PLoS One; 2019; 14(10):e0222927. PubMed ID: 31661534 [TBL] [Abstract][Full Text] [Related]
15. Glyoxalase 1 enzyme activity in erythrocytes and Ala111Glu polymorphism in type 1-diabetes patients. Sakhi AK; Berg JP; Berg TJ Scand J Clin Lab Invest; 2013 Mar; 73(2):175-81. PubMed ID: 23360186 [TBL] [Abstract][Full Text] [Related]
16. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. Wu JC; Li XH; Peng YD; Wang JB; Tang JF; Wang YF J Endocrinol Invest; 2011 Nov; 34(10):e343-8. PubMed ID: 21738003 [TBL] [Abstract][Full Text] [Related]
17. C332C genotype of glyoxalase 1 and its association with late diabetic complications. Groener JB; Reismann P; Fleming T; Kalscheuer H; Lehnhoff D; Hamann A; Roser P; Bierhaus A; Nawroth PP; Rudofsky G Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):436-9. PubMed ID: 23775136 [TBL] [Abstract][Full Text] [Related]
18. The Genetic Variants -717T>C (rs2794521), 1444G>A (rs1130864), and 1846 C > T (rs1205) of Reynoso-Villalpando GL; Casillas-Muñoz FA; Padilla-Gutiérrez JR; Sevillano-Collantes C; Moreno-Ruiz I; Del Cañizo-Gómez FJ; Valdez-Haro A; Martínez-Fernández DE; Valle Y Metab Syndr Relat Disord; 2021 Apr; 19(3):127-136. PubMed ID: 33296257 [No Abstract] [Full Text] [Related]
19. Weak association of glyoxalase 1 (GLO1) variants with autism spectrum disorder. Kovač J; Podkrajšek KT; Lukšič MM; Battelino T Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):75-82. PubMed ID: 24671236 [TBL] [Abstract][Full Text] [Related]
20. Associations of dicarbonyl stress with complement activation: the CODAM study. Xin Y; Hertle E; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; van Greevenbroek MMJ Diabetologia; 2020 May; 63(5):1032-1042. PubMed ID: 31993713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]